| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/27/2005 | CA2532475A1 Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
| 01/27/2005 | CA2532228A1 Lipid encapsulated interfering rna |
| 01/27/2005 | CA2532093A1 Solid formulation |
| 01/27/2005 | CA2531564A1 Pharmaceutical composition for inhibiting acid secretion |
| 01/27/2005 | CA2531065A1 Pharmaceutical compositions |
| 01/27/2005 | CA2495564A1 Pharmaceutical compositions |
| 01/26/2005 | EP1500664A1 Gelatin derivatives and high-molecular micelles comprising the same |
| 01/26/2005 | EP1500584A2 Control group of a second-stage regulator for scuba divers |
| 01/26/2005 | EP1500427A2 Emulsifier for low-viscosity w/o emulsions, based on partially crosslinked polyglycerin esters of polyhydroxystearic acid. |
| 01/26/2005 | EP1500407A2 Drug release stent coating process |
| 01/26/2005 | EP1500406A2 Drug release stent coating process |
| 01/26/2005 | EP1500394A1 Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences |
| 01/26/2005 | EP1500393A1 Injectable composition containing taxol |
| 01/26/2005 | EP1500390A1 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof |
| 01/26/2005 | EP1500389A1 Biofilm removing agent |
| 01/26/2005 | EP1500029A1 Infusion therapy flow rate adjustment system and method |
| 01/26/2005 | EP1500025A1 Computer assisted remotely controled infusion therapy system |
| 01/26/2005 | EP1500019A1 Centralized medical device configuration system |
| 01/26/2005 | EP1499886A1 Methods and compositions for inducing an immune response |
| 01/26/2005 | EP1499746A1 Method to inhibit cell growth using oligonucleotides |
| 01/26/2005 | EP1499721A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription factors |
| 01/26/2005 | EP1499410A1 Preparation of small crystals |
| 01/26/2005 | EP1499361A1 Novel biomaterials, their preparation and use |
| 01/26/2005 | EP1499360A2 Formulation comprising buprenorphine |
| 01/26/2005 | EP1499359A1 Temperature responsive delivery systems |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |
| 01/26/2005 | EP1499334A2 Use of compositions containing petasites for treating diseases |
| 01/26/2005 | EP1499333A2 Methods of treating ileus |
| 01/26/2005 | EP1499329A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 01/26/2005 | EP1499325A1 Methods and compositions for inhibition of irritation by disaccharide and metal ions |
| 01/26/2005 | EP1499312A1 The use of hydroxypyridone-derivatives in wound healing |
| 01/26/2005 | EP1499304A1 Liquid compositions for soft sustained-release capsules and method for production thereof |
| 01/26/2005 | EP1499303A2 Multi-phase, multi-compartment capsular system |
| 01/26/2005 | EP1499302A1 Fluid delivery device having an electrochemical pump with an anionic exchange membrane and associated method |
| 01/26/2005 | EP1499301A2 Method of stabilizing bupropion hydrochloride tablets |
| 01/26/2005 | EP1499300A1 Pharmaceutical formulations with improved bioavailability |
| 01/26/2005 | EP1499299A2 Microparticle pharmaceutical compositions for intratumoral delivery |
| 01/26/2005 | EP1499298A1 Oral administration form for difficulty soluble basic active ingredients which are applied orally |
| 01/26/2005 | EP1499297A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 01/26/2005 | EP1499296A1 Formulation of fine particles using liquefied or dense gases |
| 01/26/2005 | EP1499295A1 Sustained release metoprolol formulations |
| 01/26/2005 | EP1499294A2 Transport system in biological systems |
| 01/26/2005 | EP1499291A1 Methods and dosage forms for controlled delivery of oxycodone |
| 01/26/2005 | EP1499290A1 Warming and nonirritating lubricant compositions |
| 01/26/2005 | EP1499289A2 Volume efficient controlled release dosage form |
| 01/26/2005 | EP1499288A1 Apparatus and method for delivery of bacteria to the vaginal tract |
| 01/26/2005 | EP1499278A1 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
| 01/26/2005 | EP1499204A2 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1441704B1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 01/26/2005 | EP1335714B1 Skin friendly active ingredient plaster for transdermal administration of etheric oils |
| 01/26/2005 | EP1330237B1 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 01/26/2005 | EP1320359B1 Thermogelling biodegradable aqueous polymer solution |
| 01/26/2005 | EP1253894A4 Methods and devices for preventing transmission of sexually transmitted diseases |
| 01/26/2005 | EP1248629B1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 01/26/2005 | EP1233752B1 Radiation sensitive liposomes |
| 01/26/2005 | EP1231926B1 Biomolecular complex formed between hyaluronic acid and a biomolecule, its method of manufacture and medical uses thereof |
| 01/26/2005 | EP1165091B1 Pharmaceutical emulsions for retroviral protease inhibitors |
| 01/26/2005 | EP1131062B1 Injectable propofol formulations |
| 01/26/2005 | EP1129723B1 Combined vaccine against both hav and measle virus and method of producing it |
| 01/26/2005 | EP1107981B1 Synthesis of ring-modified cyclic peptide analogs |
| 01/26/2005 | EP1037604B1 Pharmaceutical aerosol compositions |
| 01/26/2005 | EP1007001B1 Nimesulide topical formulations in the form of liquid crystals |
| 01/26/2005 | EP1006935B1 High viscosity liquid controlled delivery system |
| 01/26/2005 | EP0994655B1 Satiety product |
| 01/26/2005 | EP0918498B1 Improved tissue injectable composition |
| 01/26/2005 | EP0866691B2 Sublingual and buccal administration of selegiline |
| 01/26/2005 | EP0820277B1 Powdered pharmaceutical formulations having improved dispersibility |
| 01/26/2005 | EP0706370B2 Use of non-ionic surfactants in stable topical retinoid compositions |
| 01/26/2005 | CN2673426Y Anal fistula anal orifice plaster-tool for treating anal fistula anal orifice disease |
| 01/26/2005 | CN1571817A Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 01/26/2005 | CN1571816A Polymeric michelle composition with improved stability |
| 01/26/2005 | CN1571795A Synthesis of cyclosporin analogs |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571691A Rotor-stator apparatus and process for the formation of particles |
| 01/26/2005 | CN1571678A Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 01/26/2005 | CN1571676A Biphasic mixtures of GLP-1 and insulin |
| 01/26/2005 | CN1571668A Salts formed of an AT1-receptor antagonist and a cardiovascular agent |
| 01/26/2005 | CN1571666A Freeze-dried pharmaceutical preparation |
| 01/26/2005 | CN1571664A Percutaneous absorption preparations |
| 01/26/2005 | CN1571663A Dosage forms, devices and methods of treatment |
| 01/26/2005 | CN1571662A Highly compressible ethylcellulose for tableting |
| 01/26/2005 | CN1571661A Taste masking spill-resistant formulation |
| 01/26/2005 | CN1571660A Solid pharmaceutical agent formulation for a piperazine urea derivative |
| 01/26/2005 | CN1571659A Granules containing acid-unstable chemical in large amount |
| 01/26/2005 | CN1571658A Pharmaceutical formulation comprising (R)-bicalutamide |
| 01/26/2005 | CN1571657A Novel cyclosporin analog microemulsion preconcentrates |
| 01/26/2005 | CN1571656A Method for treating non-neuropathic pain |
| 01/26/2005 | CN1571655A Heat generating article |
| 01/26/2005 | CN1571654A Oral care substance delivery strip |
| 01/26/2005 | CN1569890A Solid-phase synthesis process of octreotide acetate |
| 01/26/2005 | CN1569884A Method for preparing astragaloside and its use in preparation of drug for preventing and treating diabetic nephropathy |
| 01/26/2005 | CN1569861A Pharmaceutical acid addition salt of adefovir dipivoxil and its pharmaceutical use |
| 01/26/2005 | CN1569366A Nano-silver aqueous solution preparation and its preparation method, use and using method |
| 01/26/2005 | CN1569270A Method for preparing cardiovascular drug eluting stent |
| 01/26/2005 | CN1569236A Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 01/26/2005 | CN1569226A Freeze dried powder injection of hirudin and its preparation method |
| 01/26/2005 | CN1569225A Recombinant human interferon alpha nebula |
| 01/26/2005 | CN1569224A Interferon effervescence capsule for vagina used and its preparation method |
| 01/26/2005 | CN1569223A Freeze-dried interferon spray and its preparation method |